Results 31 to 40 of about 2,746 (190)
Dienogest – uus hübriidprogestiin [PDF]
Dienogest on niinimetatud hübriidprogestiinide rühma esindaja, millel tänu oma keemilisele struktuurile on nii progesterooni derivaatide tüüpilisi omadusi kui ka 19-norprogestiinide omadusi.
Sinisalu , Väino
core +1 more source
A 27-year-old patient suffering from deeply infiltrating rectovaginal endometriosis was treated with 2 mg/day dienogest vaginally for 3 months. The therapy was tolerated very well.
Andreas D. Ebert
doaj +1 more source
Germany Endometriosis Pattern Changes; Prevalence and Therapy over 2010 and 2019 Years: A Retrospective Cross Sectional Study [PDF]
Background: The aim of this study was to investigate whether the prevalence and the therapy patterns of endometriosis differ in 2010 and 2019. Materials and Methods: This retrospective cross-sectional study was based on the data from the IQVIA Disease ...
Jacob Goehring +3 more
doaj +1 more source
The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery:a Systematic Review and Meta-Analysis [PDF]
The objective of this study is to determine whether dienogest therapy after endometriosis surgery reduces the risk of recurrence compared with placebo or alternative treatments (GnRH agonist, other progestins, and estro-progestins).
Kontopantelis, Evangelos +10 more
core +1 more source
Purpose Surgery for endometriomas may cause detrimental effects on ovarian reserve. We evaluated the safety of three‐step laparoscopic surgery for endometriomas utilizing dienogest in terms of post‐surgical ovarian reserve.
Michio Kitajima +6 more
doaj +1 more source
Dienogest reduces endometrioma volume and endometriosis-related pain symptoms
This study aimed to evaluate the efficacy and adverse effects of dienogest for the treatment of endometriomas. Dienogest (2 mg/day) was administered to patients with endometrioma continuously through the 6-month study period.
Semih Z. Uludag +3 more
core +1 more source
Postoperative management of patients with endometriosis
Aim: to assess the effectiveness of using dienogest in combination with postoperative interventions in patients with endometriosis.Materials and methods.
Ju. E. Dobrokhotova +2 more
doaj +1 more source
Abstract Objective To compare pain, menstrual flow, and quality of life (QoL) between women undergoing surgery for endometriosis only compared with women with endometriosis and coexisting adenomyosis. Methods A cross‐sectional study, set in two tertiary hospitals, of reproductive‐aged women (18–50 years) with a preoperative imaging diagnosis of ...
Mariana Matzenbacher Brunoro +5 more
wiley +1 more source
Estradiol Valerate/Dienogest: A Novel Oral Contraceptive
Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of the new oral contraceptive estradiol valerate/dienogest. Data Sources: Searches of PubMed (1966-July 2011) and International Pharmaceutical Abstracts (1970-July 2011) were ...
Renee Rose, Karen L Whalen
core +1 more source
Membranous dysmenorrhea and decidual casts: A scoping review
Abstract Background Membranous dysmenorrhea, characterized by the expulsion of intact endometrial tissue rather than gradual dissolution during menstruation, occasionally presents as a decidual cast—a complete triangular mold of the uterine cavity. This poorly understood condition is likely underdiagnosed.
Lovisa Brehmer, Hedvig Engberg
wiley +1 more source

